The presence of PR3 or MPO-ANCA is highly predictive of pauci-immune glomerulonephritis in an appropriate clinical presentation, warranting early treatment for patients who present with organ- or life-threatening disease [10]. This evidence concerns the gene PRTN3 and glomerulonephritis.